Sparc Life

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
page
e-landing-page
elementor_library
elementskit_template
elementskit_widget
elementskit_content
elementor-hf
custom-css-js
cool_timeline
jobpost_applicants
jobpost
wpforms
project
services
acf-taxonomy
acf-post-type
[ivory-search id="19500" title="Custom Search Form"]

R&D Pipeline

Asset / Program

MoA

Discovery

Preclinical

Phase 1

Phase 2

Phase 3

Neurology

Vodobatinib
(SCC-138)

c-ABL
Inhibitor

Parkinson’s Disease
Lewy Body Dementia
Alzheimer’s Disease

Oncology

Vodobatinib
(SCO-088)

BCR-ABL
Inhibitor

Refractory CML

SBO-154

Anti-MUC-1 ADC

Multiple Tumors

Immunology

Vibozilimod
(SCD-044)

Selective
S1PR1 Agonist

Psoriasis
Atopic Dermatitis

SCD-153

Undisclosed

Alopecia Areata

Vodobatinib (SCC-138)

Phase 2

c-ABL Inhibitor for Parkinson’s Disease

Vodobatinib (SCC-138)

Phase 2

c-ABL Inhibitor for Lewy Body Dementia

Vodobatinib (SCC-138)

Preclinical

c-ABL Inhibitor for Alzheimer’s Disease

Vodobatinib (SCO-088)

Phase 2

BCR-ABL Inhibitor for Refractory CML

SBO-154

Preclinical

Anti-MUC-1 ADC for Multiple Tumors

Vibozilimod (SCD-044)

Phase 2

Selective S1PR1 Agonist for Psoriasis

Vibozilimod (SCD-044)

Phase 2

Selective S1PR1 Agonist for Atopic Dermatitis

SCD-153

Phase 1

Undisclosed for Alopecia Areata
  • Neurology
  • Oncology
  • Immunology